ANIDO ARMANDO (Chairman & Chief Exec. Officer) sold 1.9% of their position (11.90K shares) of ZYNERBA PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $13.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/20/2022ACC: 0001062993-22-016555
DirectorOfficer· Chairman & Chief Exec. Officer
Since Aug 2018
+31.27K
Net shares
Net buyer
$13.1K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
43.16K acquired · 11.90K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+43.16K
Price / share
—
Trade value
—
% of position
7.4%
7/18/2022
580.42K→623.59K
Common Stock
Direct
Shares
−11.90K
Price / share
$1.10
Trade value
$13.09K
% of position
1.9%
7/19/2022
623.59K→611.69K
Total
Net shares
+31.27K
Net value
-$13.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/18/2022 | A · Award | +43.16K | — | — | 7.4% | 580.42K | 623.59K |
| Common Stock Direct | 7/19/2022 | S · Sale | −11.90K | $1.10 | $13.09K | 1.9% | 623.59K | 611.69K |
| Total | +31.27K | -$13.09K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned13.30K
Common Stock
IndirectShares owned26.59K
Total
39.89K indirect39.89K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 13.30K | Indirect |
| Common Stock | 26.59K | Indirect |
| Total | 39.89K | 39.89K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported